213 results found.
                  
Integra LifeSciences Posts 3Q15 Revenue
Integra LifeSciences posted 3Q15 Orthopedics and Tissue Technologies revenue of US $79.2MM, +32% vs. 3Q14.
M&A Update: Wright Medical Completes Merger with Tornier
By Julie Vetalice On October 1, 2015, Wright Medical announced successful completion of its merger with Tornier, forming Wright Medical Group N.V. Wright anticipates revenues to grow in the mid-teens with cost synergies in the range of US $40 ...
Integra Completes Acquisition of Tornier Products
Integra LifeSciences closed its acquisition of the U.S. rights to Tornier's Salto Talaris®...
Wright Medical and Tornier Complete Merger
Wright Medical successfully completed its merger with Tornier, forming Wright Medical Group N.V. ...
NASS Preview: Products and Companies to Watch
By Julie Vetalice Spine-centric product news and personnel announcements are ramping up as we near the mid-October annual meeting of NASS, the North American Spine Society. Recent analyst notes suggest that pure-play companies continue to outperform larger diversifi...
NASS PREVIEW: A Guide to the Recently-merged in Spine
Who bought whom? A look at mergers and other initiatives that are changing up the names behind the products at this year’s NASS meeting. Amendia + Baxano + Custom Spine + SpineSelect Amendia has logged the most acquisitions in the space ...
BARE BONES® - September 3, 2015
Integra LifeSciences entered into a definitive agreement to acquire U.S. rights to Tornier's Salto Talaris® and Salto XT™ ankle replacements and Futura...
BARE BONES® - August 5, 2015
Integra LifeSciences priced a public offering of 3.3MM shares of common stock at $61/share, expected to close on 8/10/15. Net proceeds will support reduction of outstanding borrowings. (
BARE BONES® - July 30, 2015
Integra LifeSciences reported 2Q15 Orthopedics & Tissue Technologies revenue of US $63.8MM, +10% vs. 2Q14. (
The Consolidation Climate: What Trends Prevail?
By Carolyn LaWell Through the first half of 2015, the number of merger and acquisition transactions closed has kept pace with the amount of deals that took place during the same time periods in ...
BARE BONES® - July 2, 2015
Integra LifeSciences completed the spin-off of its SeaSpine orthobiologics and spinal fusion hardware business. (
BARE BONES® - June 29, 2015
Integra LifeSciences (IART) entered into a definitive agreement to acquire TEI Biosciences and TEI Medical for US $312MM cash in 3Q15. While the transaction supports IART's growth initiatives ...
BARE BONES® - June 8, 2015
Integra LifeSciences (IART) intends to complete its SeaSpine spin-off on 7/1/15. SeaSpine will be an independent, publicly-traded company trading on Nasdaq as SPNE, and will own IART's orthobiologics a...
BARE BONES® - April 30, 2015
Integra LifeSciences appointed Keith Valentine as Chief Executive Officer and John Bostjancic as Chief Financial Officer of its SeaSpine spinoff. (
BARE BONES® - April 30, 2015
Integra LifeSciences reported 1Q15 Orthopedics & Tissue Technologies revenue of US $61.3MM, +12%, and Spine revenue of $32.2MM, -3% vs. 1Q14. (
BARE BONES® - February 24, 2015
Integra LifeSciences reported 2014 orthopaedic revenue of US $370.0MM, flat vs. 2013. (U.S. Extremities $143.3MM, +11.7%; U.S. Spine & Other $171.3MM, -5.8%) (Segment growth reflects constant currency.) (
2014 Revenue: Integra LifeSciences
4Q14 revenue: $98.1MM, flat (U.S. $83.4MM, +2%; ex-U.S. $14.7MM, -13%) U.S. Extremities $40.3MM, +17% U.S. Spine & Other $43.1MM, -8%   New product introductions (Titan Shoulder, Total Foot System 2, Freedom Wrist) + ad...
BARE BONES® - January 21, 2015
Integra LifeSciences commenced full market launch of Integra® Reinforcement Matrix, a porcine dermis biological implant for surgical reconstruction of any type of tendon injury. Manufactured ...
BARE BONES® - January 12, 2015
Integra LifeSciences acquired Metasurg's foot and ankle product portfolio, including distribution of the BioFix® amniotic-based regenerative biologic line. For 2013, Metasurg...
2014: A Recap of Strategic Activities
To begin 2015, let’s look back at what fueled growth in 2014. Here, we present companies that ha...
2014: A Recap of Strategic Activities in Orthobiologics
Editor’s Note: This segment-specific article is excerpted from the full version, covering major market segments, appearing in ORTHOKNOW January 2015. To begin...
2014: A Recap of Strategic Activities in Spine
Editor’s Note: This segment-specific article is excerpted from the full version, covering major market segments, appearing in ORTHOKNOW January 2015. To begin...
BARE BONES® - November 13, 2014
Integra LifeSciences commenced controlled U.S. launch of the Integra® Expandable Interbody System, intended for use with bone graft and supplemental fixation for posterior or transforaminal lumbar int...
BARE BONES® - November 12, 2014
Integra LifeSciences (IART) commenced limited market release of Integra® Shaped Strip and Pocket Strip, 100% human allograft demineralized bone matrix implants. The product w...
BARE BONES® - November 3, 2014
Integra LifeSciences reported 3Q14 orthopaedic revenue of ~US $78.7MM, -10.6% from 3Q13. (U.S. Extremities $36.7MM, +15%, U.S. Spine & Other $42.0MM, -11%) (
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group